Litigation Details for SHIRE DEVELOPMENT LLC v. INVAGEN PHARMACEUTICALS, INC. (D.N.J. 2015)
✉ Email this page to a colleague
SHIRE DEVELOPMENT LLC v. INVAGEN PHARMACEUTICALS, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-01-19 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-12-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 7,381,428 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SHIRE DEVELOPMENT LLC v. INVAGEN PHARMACEUTICALS, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SHIRE DEVELOPMENT LLC v. INVAGEN PHARMACEUTICALS, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-17 | 164 | 2. Plaintiffs’ claim regarding U.S. Patent No. 7,381,428 is hereby DISMISSED WITHOUT PREJUDICE…Defendant’s counterclaims regarding U.S. Patent No. 7,381,428 are hereby DISMISSED WITHOUT PREJUDICE. …parties’ claims and counterclaims regarding U.S. Patent No. 5,968,976 are hereby DISMISSED WITHOUT… 19 December 2017 2:15-cv-00367 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
